PanGenomic Health

What PanGenomic Health does

PanGenomic Health is a Vancouver-based public benefit corporation (CSE: NARA, FRA: LL30) that develops AI-powered digital health products focused on personalized natural and complementary medicine for mental wellness. Its product portfolio includes the NARA consumer mental health app, the Mindleap telehealth platform (with an RWE platform launching Q1 2026), MUJN Diagnostics point-of-care biomarker testing, the Agenta Health eCommerce site for supplements and DNA testing kits (launched Q3 2025), and the NaraCare.AI platform (expected Q4 2025) — all underpinned by the proprietary Nustasis AI engine that integrates genomic, proteomic, and biomarker data with daily check-ins to recommend natural remedies.

The company serves two primary segments: individual consumers seeking natural mental health and wellness alternatives (including a women's hormonal health vertical) accessible via mobile app stores and direct eCommerce across North America, Europe, Latin America, and Oceania; and healthcare practitioners plus CAM industry participants who use the MUJN clinical workflow and will access the upcoming Mindleap RWE platform subscriptions. Revenue mechanics are a blend of consumer app subscriptions, one-time DNA report sales, eCommerce transactions, telehealth consultations, and emerging B2B RWE subscriptions, though the company has reported $0 revenue across 2022-2025.

PanGenomic operates as a small team (11-50 employees) led by CEO Maryam Marissen with co-founders Robert Nygren (Executive Chair) and Vincent Lum (CEO of subsidiary MUJN Diagnostics), and has gone through six product launches and a Hong Kong AI Centre expansion during 2025. The company is in a pre-commercial phase, having raised approximately $2.3M CAD across three private placements since 2023, completed two share consolidations (10:1 in March 2024 and 5:1 in November 2024), and faced two Management Cease Trade Orders (April 2024, May 2025) for late financial filings, indicating ongoing capital and governance constraints.

Name

PanGenomic Health

Legal name

PanGenomic Health Inc.

Website

https://pangenomic.com

Company type

Public

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

PanGenomic Health is a Vancouver-based public benefit corporation building AI-powered consumer health apps, telehealth, diagnostics, and eCommerce platforms that deliver personalized natural remedy recommendations for mental wellness to consumers and CAM industry participants.

Ownership category

akta.pro rank

Product category

Digital Health Platform

NAICS

Offices of Physicians, Mental Health Specialists (621112), Software Publishers (5132), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care) (HLALAFAK)

akta.pro secondary industries

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Healthcare & Wellness Personalization (HDAAAGAI), AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Mental health apps
• Genomic health analysis
• Telehealth services
• Natural wellness platform
• Diagnostic testing tools

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Consumer App Services: Revenue from Nara and Mindleap mobile applications offering mental health support, natural remedy curation, telehealth access to practitioners, and personalized health insights based on genomic and proteomic data.
2. DNA Reports: Sale of personalized DNA reports including NARA DNA Reports, Women's Hormonal Health DNA Report, and other genetic analysis products providing insights into health, wellness, and supplement recommendations.
3. Agenta Health eCommerce: eCommerce platform for alternative health products including supplements and wellness items, accessible at agentahealth.store and agentahealth.ai.
4. RWE Platform Subscriptions: Subscription-based access to Mindleap RWE platform for manufacturers, distributors, retailers, researchers and health practitioners interested in evidence levels for CAM health solutions.
5. Telehealth Services: Online access to alternative health practitioners through Mindleap telehealth platform providing consultations and professional wellness guidance.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

PanGenomic Health operates an AI-powered health technology platform that delivers personalized natural remedy recommendations through consumer mobile apps (NARA, Mindleap), diagnostic tools (MUJN), and the Agenta Health eCommerce platform. The platform integrates genomic data analysis (pharmacogenomics, nutrigenomics, proteomics), digital biomarker tracking, and telehealth access to alternative health practitioners to provide personalized, science-backed holistic health solutions. The Nustasis AI Platform and NaraCare.AI serve as the underlying intelligence layer, leveraging adaptive deep learning and predictive analytics to inform every consumer-facing product.

Product overview

PanGenomic Health offers a portfolio of interconnected health technology products centered on AI-powered personalized natural health solutions. The core offerings include the NARA mental health app, Mindleap telehealth platform, and MUJN Diagnostics, all supported by the proprietary Nustasis AI Platform. The NaraCare.AI platform serves as the overarching AI platform integrating insights from all products to deliver personalized alternative health recommendations. The Agenta Health eCommerce platform provides product sales functionality, while the PlantGx platform delivers personalized natural remedy regimens. DNA Reports offer genetic insights for personalized health recommendations. The company also operates Mindleap as a Real-World Evidence platform for CAM research.

Differentiator

Problem solved

Functional benefit

Brands

• NARA: Mental health app offering natural health solutions with focus on lifestyle, hormones, and genetic analysis for mind-and-body wellness
• Mindleap
• MUJN Diagnostics
• Agenta Health
• NaraCare.AI
• PlantGx

Products and services

• NARA App Consumer mental health app that curates natural remedies for individuals to manage and improve their mental wellness. Offers personalized insights and evidence-backed resources based on genomic analysis, daily check-ins, medication regimen, and health data. Targets health-conscious consumers seeking natural, science-backed alternatives to pharmaceutical treatments.
• Mindleap Telehealth Platform Mental health platform providing audio content, blogs, a mental health tracker, and access to professional services through telehealth access to vetted alternative health practitioners for mental well-being. Also the foundation for the upcoming Real-World Evidence (RWE) platform.
• MUJN Diagnostics Health insights platform supported by point-of-care testing, structured symptom tracking, and automated trend analysis for biomarker testing. Promotes positive health outcomes with precise and efficient diagnostic processes and patient-practitioner connection features.
• Agenta Health eCommerce Platform eCommerce platform and personal health agent that harnesses AI to craft supplement and longevity plans uniquely tailored to a personal health blueprint. Provides personalized online shopping experiences for alternative health products and Agenta branded DNA testing kits.
• NaraCare.AI Platform AI-powered platform for personalized alternative health product recommendations that leverages insights from the NARA mental health app, Mindleap telehealth platform, and MUJN diagnostic tools. Built using leading AI models to present personalized information about alternative health treatments.
• Nustasis AI Platform Proprietary AI platform that supports consumer applications and diagnostic tools with adaptive AI and digital biomarker technology. Leverages adaptive deep learning and predictive analytics for personalized integrative technology-driven care, incorporating proprietary algorithms, peer-reviewed science, and biomarker diagnostics data to provide contextual, safe, and concise health recommendations.
• Mindleap Real-World Evidence (RWE) Platform Subscription-based Real-World Evidence platform collecting and analyzing health data from clinical research studies, historical human use documentation, and modern use evidence to support non-pharmaceutical Complementary & Alternative Medicine (CAM) health solution claims. Built using leading LLM platforms. Targets manufacturers, distributors, retailers, researchers, and health practitioners in the CAM market.
• DNA Reports (including Women's Hormonal Health DNA Report) Personalized DNA reports including NARA DNA Reports and Women's Hormonal Health DNA Report that provide genetic data insights for a precision health approach to mind-and-body wellness, including diet, fitness, metabolism, brain function, and supplement recommendations.
• PlantGx Platform Platform that delivers personalized natural remedy regimen options to help individuals and healthcare practitioners support mental wellness through evidence-backed information about natural remedy alternatives to pharmaceutical drugs (Nara Plant Library).

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Partnerships

Four partnerships are on record, tiered major, minor and core.

• Leading DNA Testing Technology DevelopermajorTechnology or Integration · 20 October 2025PanGenomic Health is working with a leading developer of DNA testing technologies to market Agenta branded DNA testing kits to health-conscious consumers. The initial roll-out campaign targets Canada with plans to expand into the United States in early 2026. DNA tests deliver data into the Nara.Care AI platform for actionable health insights.
• Strategic Advisory Firm (Hong Kong)minorStrategic or Co-development Partner · 23 September 2025Mindleap Health, a wholly-owned subsidiary, is establishing its Health AI Centre operations in Hong Kong with support from a strategic advisory firm based in Hong Kong. The centre will include development, research and marketing resources to advance the Mindleap RWE platform for CAM.
• Fairfax Partners Inc.minorGTM or Marketing Partner · 20 June 2025Fairfax Partners Inc. of Vancouver, BC provides investor relations, communications infrastructure and marketing services to PanGenomic Health. The services agreement remains in effect for six months starting June 20, 2025, with a monthly cash fee of $5,000 plus applicable taxes. Fairfax is an unrelated third party service provider.
• Psy Integrated HealthcoreStrategic or Co-development PartnerPsy Integrated Health is a health practitioner-controlled services organization with a mission to improve wellness through integrative health practices and evidence-supported plant medicines. It recently acquired Empower Health Clinic, a leading provider of integrative health delivery models. PanGenomic works closely with Psy Integrated as its clinical partner in developing the tools offered by MUJN, gaining access to a multi-disciplinary team of health practitioners who treat patients facing mental health concerns.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Calm: Calm is a leading direct-to-consumer mental wellness and meditation app competing for the same health-conscious consumer audience as NARA, with overlapping freemium subscription model and content-driven engagement loop.
• BetterHelp: BetterHelp provides online therapy and telehealth access to licensed counselors — directly comparable to Mindleap's telehealth offering to vetted practitioners in the same mental health consumer segment.
• Wysa: Wysa is an AI-driven mental health chatbot offering CBT-based self-guided support — closely comparable to PanGenomic's AI-powered personalized recommendations inside NARA and the Nustasis platform.
• Talkspace: Talkspace is a publicly traded telehealth therapy platform with both direct-to-consumer and B2B channels, mirroring PanGenomic's Mindleap telehealth positioning and consumer-plus-enterprise GTM motion.
• 23andMe: 23andMe is a direct-to-consumer DNA testing company that delivers genetic insights into health and wellness — directly comparable to PanGenomic's Agenta DNA testing program and DNA Reports product line.
• Headspace Health: Headspace Health offers a direct-to-consumer mental wellness app with meditation, coaching, and therapy services — overlapping most directly with PanGenomic's NARA and Mindleap consumer mental health apps in target market and business model.

Emerging players

• Viome: Viome combines AI-driven microbiome testing with personalized supplement recommendations — a close analog to PanGenomic's combined DNA testing, AI personalization, and Agenta Health eCommerce supplement offering.
• Woebot Health: Woebot Health is an AI-driven mental health chatbot platform that combines clinically validated CBT with conversational AI — overlapping with PanGenomic's NARA app personalization engine and AI-driven mental wellness positioning.
• Lyra Health: Lyra Health is a venture-backed mental health platform focused on enterprise B2B2C delivery of therapy and coaching — comparable to PanGenomic's emerging practitioner-network model via Psy Integrated Health and Mindleap telehealth.
• Oura: Oura provides wearable biomarker tracking with AI-driven personalized health insights, intersecting with PanGenomic's MUJN Diagnostics and biomarker-based recommendation engine through digital biomarker capture and analytics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/pangenomic
• Facebookfacebook.com/PanGenomic
• LinkedInlinkedin.com/company/pangenomic-health
• Instagraminstagram.com/pangenomic_health

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries3 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PanGenomic Health